Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Update

Arcadia Biosciences, Inc. (NASDAQ:RKDA) was the target of a large decrease in short interest in June. As of June 30th, there was short interest totaling 23,325 shares, a decrease of 91.5% from the June 15th total of 273,134 shares. Currently, 1.2% of the company’s stock are short sold. Based on an average trading volume of 95,314 shares, the days-to-cover ratio is currently 0.2 days.

Arcadia Biosciences Trading Up 1.4%

NASDAQ:RKDA traded up $0.01 during mid-day trading on Friday, reaching $0.68. The company’s stock had a trading volume of 44,798 shares, compared to its average volume of 1,490,680. The stock has a market cap of $1.49 million, a P/E ratio of -0.12 and a beta of 0.54. The firm’s fifty day moving average price is $0.90 and its two-hundred day moving average price is $1.53. Arcadia Biosciences has a 12-month low of $0.63 and a 12-month high of $6.71.

Arcadia Biosciences (NASDAQ:RKDA) last announced its quarterly earnings results on Thursday, May 14th. The basic materials company reported ($2.11) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.80) by ($1.31). Arcadia Biosciences had a negative net margin of 195.94% and a negative return on equity of 113.73%. The company had revenue of $1.10 million for the quarter, compared to analysts’ expectations of $1.60 million.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings lowered Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a report on Thursday, June 25th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has an average rating of “Sell”.

About Arcadia Biosciences

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision?breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.